HCM
DALS

Highbridge Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Highbridge Capital Management’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90,891
Closed -$881K – 609
2022
Q3 		$881K Buy
+90,891
New +$884K 0.01% 347

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Highbridge Capital Management's DALS Position: Q4 2022 in Review

Highbridge Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2022, closing a stake of 90,891 shares — an estimated $881K sold.

Highbridge Capital Management first reported a position in DALS in Q3 2022 and held it in 1 quarter. The position peaked at $881K in Q3 2022. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • Highbridge Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Highbridge Capital Management sold 90,891 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $881K.
  • Highbridge Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Highbridge Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $881K in Q3 2022.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Highbridge Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.